Phenotype
|
Fish
|
Conditions
|
Figures
|
myocardium trabecular layer complexity, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 2
from Yang et al., 2019
|
cardiac ventricle nrg1 expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4,
Fig. 5
from Yang et al., 2019
|
heart increased size, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 1
from Yang et al., 2019
|
cardiac ventricle myl7 expression decreased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle igfbp2a expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle myca expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
yolk morphology, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 1
from Yang et al., 2019
|
cardiac ventricle mybpc3 expression decreased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle pax6a expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
developmental growth arrested, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 1
from Yang et al., 2019
|
cardiac ventricle egr1 expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4,
Fig. 5
from Yang et al., 2019
|
cardiac ventricle ing5a expression decreased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle cacna1c expression decreased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle ccl25b expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle fosab expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle ets2 expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
erythrocyte differentiation decreased occurrence, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. S2
from Yang et al., 2019
|
cardiac ventricle mmp13a.1 expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
heart ab2-akt labeling increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 5
from Yang et al., 2019
|
cardiac ventricle egr2b expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle ptk6b expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle junbb expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle cxcr4b expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
heart ab6-mapk labeling increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 5
from Yang et al., 2019
|
cardiac ventricle cxcl12b expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle jak3 expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
developmental growth delayed, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 1
from Yang et al., 2019
|
cardiac ventricle tnnt2a expression decreased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle increased size, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 2
from Yang et al., 2019
|
heart blood circulation decreased rate, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 2
from Yang et al., 2019
|
trabecular layer decreased thickness, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 2
from Yang et al., 2019
|
cardiac ventricle foxo3a expression decreased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle cxcr3.2 expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
cardiac ventricle tgfa expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
atrium dilated, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 2
from Yang et al., 2019
|
cardiac ventricle mef2aa expression decreased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
whole organism decreased life span, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 1
from Yang et al., 2019
|
cardiac ventricle gja5a expression spatial pattern, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 5
from Yang et al., 2019
|
cardiac ventricle junba expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4,
Fig. 5
from Yang et al., 2019
|
cardiac ventricle cxcl12a expression increased amount, abnormal
|
zfpm1nju204/nju204
|
standard conditions
|
Fig. 4
from Yang et al., 2019
|
heart increased size, abnormal
|
zfpm1nju207/nju207
|
standard conditions
|
Fig. S1
from Yang et al., 2019
|
yolk morphology, abnormal
|
zfpm1nju207/nju207
|
standard conditions
|
Fig. S1
from Yang et al., 2019
|
developmental growth delayed, abnormal
|
zfpm1nju207/nju207
|
standard conditions
|
Fig. S1
from Yang et al., 2019
|
heart increased size, abnormal
|
zfpm1nju208/nju208
|
standard conditions
|
Fig. S1
from Yang et al., 2019
|
yolk morphology, abnormal
|
zfpm1nju208/nju208
|
standard conditions
|
Fig. S1
from Yang et al., 2019
|
developmental growth delayed, abnormal
|
zfpm1nju208/nju208
|
standard conditions
|
Fig. S1
from Yang et al., 2019
|
heart constricted, abnormal
|
zfpm1nju204/nju204; s843Tg
|
standard conditions
|
Fig. S2
from Yang et al., 2019
|
endocardium cell nrg1 expression increased amount, abnormal
|
zfpm1nju204/nju204; s843Tg
|
standard conditions
|
Fig. 5
from Yang et al., 2019
|
cardiac ventricle shape, abnormal
|
zfpm1nju204/nju204; twu34Tg
|
standard conditions
|
Fig. 3
from Yang et al., 2019
|
trabecular layer morphology, abnormal
|
zfpm1nju204/nju204; twu34Tg
|
standard conditions
|
Fig. 3
from Yang et al., 2019
|
trabecular layer decreased thickness, abnormal
|
zfpm1nju204/nju204; twu34Tg
|
standard conditions
|
Fig. 3
from Yang et al., 2019
|
trabecular layer structure, abnormal
|
zfpm1nju204/nju204; twu34Tg
|
standard conditions
|
Fig. 3
from Yang et al., 2019
|
cardiac ventricle heart trabecula formation increased occurrence, abnormal
|
zfpm1nju204/nju204; twu34Tg
|
standard conditions
|
Fig. 3
from Yang et al., 2019
|
trabecular layer decreased length, abnormal
|
zfpm1nju204/nju204; twu34Tg
|
standard conditions
|
Fig. 3
from Yang et al., 2019
|
cardiac ventricle dilated, abnormal
|
zfpm1nju204/nju204; twu34Tg
|
standard conditions
|
Fig. 3
from Yang et al., 2019
|
cardiac ventricle increased size, abnormal
|
zfpm1nju204/nju204; twu34Tg
|
standard conditions
|
Fig. 3
from Yang et al., 2019
|
cardiac ventricle cardiac muscle cell proliferation increased occurrence, abnormal
|
zfpm1nju204/nju204; twu34Tg
|
standard conditions
|
Fig. 5
from Yang et al., 2019
|
heart looping delayed, abnormal
|
zfpm1nju204/nju204; twu34Tg
|
standard conditions
|
Fig. S2
from Yang et al., 2019
|